Behçet's syndrome: one year in review 2023
- PMID: 37877363
- DOI: 10.55563/clinexprheumatol/7kdo9x
Behçet's syndrome: one year in review 2023
Abstract
This critical review of studies on Behçet's syndrome published during 2022 includes studies on epidemiology, patients' perspective, pathogenesis, diagnosis, clinical features and management. Studies on pathogenesis included potential biomarkers mostly related to macrophages, neutrophil and cytokine balance, new GWAS and polymorphism studies, and studies on miRNAs and long non-coding RNAs. Clinical studies showed that application of pneumococcal vaccine to the prick site increased the sensitivity and specificity of the pathergy test and the prevalence of AA amyloidosis had decreased over the years. Studies on management indicated that more data are needed to understand the effect of apremilast on BS manifestations other than oral ulcers, and new BS manifestations may develop during treatment with infliximab. Other biologics and Jak inhibitors might be an option for patients who are refractory to TNF-α inhibitors. Moreover, endovascular repair of arterial aneurysms might be an alternative to open surgery.
Similar articles
-
One year in review 2019: Behçet's syndrome.Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):3-17. Epub 2019 Dec 9. Clin Exp Rheumatol. 2019. PMID: 31856939 Review.
-
Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet's Syndrome and Sarcoidosis: A Single Center Study of 131 Patients.Ocul Immunol Inflamm. 2022 Jan 2;30(1):223-230. doi: 10.1080/09273948.2020.1791346. Epub 2020 Aug 20. Ocul Immunol Inflamm. 2022. PMID: 32815752
-
Resolution of Behçet's syndrome associated pulmonary arterial aneurysms with infliximab.Semin Arthritis Rheum. 2011 Dec;41(3):482-7. doi: 10.1016/j.semarthrit.2011.02.006. Epub 2011 May 4. Semin Arthritis Rheum. 2011. PMID: 21546064
-
Predictors of infliximab refractory intestinal Behçet's syndrome: A retrospective cohort study from the Shanghai Behçet's syndrome database.Mod Rheumatol. 2023 Jan 3;33(1):207-216. doi: 10.1093/mr/roab127. Mod Rheumatol. 2023. PMID: 34932796
-
Behçet's syndrome: one year in review 2022.Clin Exp Rheumatol. 2022 Sep;40(8):1461-1471. doi: 10.55563/clinexprheumatol/h4dkrs. Epub 2022 Jul 26. Clin Exp Rheumatol. 2022. PMID: 35894066 Review.
Cited by
-
Profile of immunological biomarkers in Behcet's syndrome: a large-scale single-center real-world study.Clin Exp Med. 2024 Aug 28;24(1):201. doi: 10.1007/s10238-024-01462-5. Clin Exp Med. 2024. PMID: 39196452 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical